Rhonda M Cooper-Dehoff

Rhonda M Cooper-Dehoff Pharm.D., M.S., FAHA, FACC, FCCP

Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6184
Business Email: dehoff@cop.ufl.edu

About Rhonda M Cooper-Dehoff

Dr. Cooper-DeHoff is a Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine at the University of Florida.

Honors & Awards

Fellow
2014 · American College of Clinical Pharmacy
Research Featured
2009 · American Society of Hypertension
Clinical Science Award
2008 · Consortium for Southeastern Hypertension Control
Fellow
2007 · American Heart Association

Research Profile

Dr. Cooper-DeHoff’s research interests include hypertension, metabolic syndrome, diabetes, coronary artery disease and antihypertensive drug-induced diabetes, as well as the impact of pharmacogenetic variations in each of these areas. She’s also the lead investigator of the hypertension working group within the Patient-Centered Outcomes Research Institute-funded Clinical Data Research Network — OneFlorida — which affords trainees the opportunity to work at an epidemiologic level to explore population-level questions about hypertension. Trainees also learn about the complexities and benefits of working in electronic health record data at the research level. Dr. Cooper-DeHoff’s resistant hypertension research includes mass spectrometry analysis of antihypertensive drugs, metabolomics and gut microbiota available for analysis.

Publications

2018 The American journal of medicine. Supplement

Grants

November 2018ACTIVE
Cardiovascular Health Collaborative Research Group
PATIENT-CENTERED OUTCOMES RES INST · Principal Investigator
September 2018ACTIVE
Using PCORnet to Compare Blood Pressure Control Strategies
UNIV OF CALIFORNIA SAN FRANCISCO · Principal Investigator
July 2018ACTIVE
Advancing Personalized Hypertension Care through Big Data Science
NATL INST OF HLTH NHLBI ·
June 2018ACTIVE
INTEGRATIVE DATA APPROCACHES FOR RESISTANT HYPERTENSION IDENTIFICATION AND PREDICTION
NATL INST OF HLTH NHLBI ·
September 2017ACTIVE
Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
US ARMY MED RES ACQUISITION ·
January 2017 – August 2018
PCORnet Cardiovascular Health Collaborative Research Group
UNIV OF CALIFORNIA SAN FRANCISCO · Principal Investigator
October 2015 – March 2019
OneFlorida Clinical Research Consortium Phase II
PATIENT-CENTERED OUTCOMES RES INST · Project Manager
April 2015ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
August 2010 – July 2017
Pharmacogenomic Evaluation of Antihypertensive Responses.
NATL INST OF HLTH NIGMS ·
July 2007 – August 2016
Clinical and Translational Science Institute
UF RESEARCH FOU · Project Manager

Patents

Published April 2004
Combination Drug Therapy for Treating Hypertension
US 2005-0032784 A1
Issued November 1999
Method & System For Interactive Prescription and Distribution of Perscriptions in Conducting Medical Studies (CON)
5,991,731

Education

2007
M.S.
University of Florida
1986
Pharm.D.
University of California at San Fransisco